Sherry A Pierce Selected Research

Anemia

4/2024	Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study.
6/2002	Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinoside.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sherry A Pierce Research Topics

Disease

14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 06/2002
6	Neoplasms (Cancer) 11/2023 - 03/2004
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 06/2002
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 01/2016
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2006 - 01/2002
2	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 07/2019
2	Anemia 04/2024 - 06/2002
2	Disease Progression 01/2019 - 10/2013
2	Infections 03/2004 - 01/2002
2	Acute Promyelocytic Leukemia 03/2004 - 06/2002
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023
1	Leukemia 01/2021
1	Second Primary Neoplasms (Neoplasms, Second) 05/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2018
1	Thrombocytopenia (Thrombopenia) 05/2017
1	Philadelphia Chromosome 08/2015
1	Atrial Fibrillation 10/2013
1	Death (Near-Death Experience) 10/2013
1	Respiratory Insufficiency (Respiratory Failure) 10/2013
1	Renal Insufficiency (Renal Failure) 10/2013
1	Lymphoma (Lymphomas) 04/2006
1	Hyperglycemia 03/2004
1	Pathologic Complete Response 06/2002
1	Hematologic Neoplasms (Hematological Malignancy) 01/2002
1	Mucositis 01/2002

Drug/Important Bio-Agent (IBA)

4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 06/2002
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2016
3	Azacitidine (5 Azacytidine)FDA Link 11/2021 - 01/2019
3	venetoclaxIBA 01/2021 - 01/2021
2	Decitabine FDA Link 01/2021 - 01/2020
2	ruxolitinibIBA 01/2020 - 07/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2004 - 01/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2004 - 01/2002
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2004 - 01/2002
2	Vincristine (Oncovin)FDA LinkGeneric 03/2004 - 01/2002
2	Gemtuzumab (Mylotarg)FDA Link 06/2002 - 06/2002
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 06/2002 - 06/2002
1	ACE-011IBA 04/2024
1	Cladribine FDA LinkGeneric 01/2023
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2023
1	Programmed Cell Death 1 ReceptorIBA 11/2021
1	pembrolizumabIBA 11/2021
1	LigandsIBA 11/2021
1	avelumabIBA 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	isavuconazoleIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	NivolumabIBA 01/2019
1	Core Binding Factors (Core-Binding Factor)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 04/2006
1	Methylprednisolone FDA LinkGeneric 03/2004
1	Methotrexate (Mexate)FDA LinkGeneric 03/2004
1	Glucose (Dextrose)FDA LinkGeneric 03/2004
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 03/2004
1	HLA-DR Antigens (HLA-DR)IBA 03/2004
1	Interleukin-11 (Interleukin 11)IBA 06/2002
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2002
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2002
1	Filgrastim (Neupogen)FDA Link 01/2002

Therapy/Procedure

10	Therapeutics 11/2023 - 11/2011
5	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
2	Remission Induction 01/2021 - 01/2002
2	Salvage Therapy 01/2018 - 10/2013
2	Induction Chemotherapy 03/2004 - 01/2002
1	Stem Cell Transplantation 01/2023
1	Artificial Respiration (Mechanical Ventilation) 10/2013
1	Consolidation Chemotherapy 01/2002